Disease/Infection News

RSS

How pharma money colors Operation Warp Speed’s quest to defeat COVID

April 16 was a big day for Moderna, a Massachusetts biotech company on the verge of becoming a front-runner in the U.S. government's race for a coronavirus vaccine. It had received roughly half a billion dollars in federal funding to develop a COVID shot that might be used on millions of Americans.

30 Nov 2020

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Researchers have published a study on the efficacy of steam inhalations as another possible treatment to help mitigate SARS-CoV-2 infection.

30 Nov 2020

Researchers highlight potential advantages of mucosal vaccine

Anyone who has undergone a nasal swab or saliva test for COVID-19 knows that the virus is most easily detected in the nose and mouth.

30 Nov 2020

WHO calls on global health partners to step up the fight against malaria

The World Health Organization (WHO) is calling on countries and global health partners to step up the fight against malaria, a preventable and treatable disease that continues to claim hundreds of thousands of lives each year.

29 Nov 2020

Warmer countries less vulnerable to COVID-19, study finds

In fact, a new study by a researcher at the University College London (UCL) suggests that global temperature plays an essential role in the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19.

29 Nov 2020

Asymptomatic patients have higher SARS-CoV-2 viral loads than symptomatic patients, study says

Now, a surprising new study shows that asymptomatic COVID-19 patients have greater viral loads than those with symptoms.

29 Nov 2020

Healthy diet plays vital role in warding off COVID-19

A researcher at the School of Human Development and Health, Faculty of Medicine, University of Southampton, explored nutrition's role in boosting the immune system to combat COVID-19 infection.

29 Nov 2020

Research suggests importance of vitamin D for good health in the context of COVID-19

A researcher at the UNC Nutrition Research Institute, University of North Carolina revealed that avoiding vitamin D deficiency may help reduce the risk of severe COVID-19.

29 Nov 2020

Virusend TX-10 detergent rapidly reduces SARS-CoV-2 infectivity

Researchers at Liverpool School of Tropical Medicine have conducted a study showing that a novel disinfectant called Virusend TX-10 is highly effective at inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

29 Nov 2020

Female reproductive hormones may be protective against COVID-19

In an article recently published in Trends in Endocrinology & Metabolism, Graziano Pinna from the University of Illinois in Chicago outlines some of the evidence suggesting that female reproductive hormones may play a role in the sex bias that has been observed in coronavirus disease 2019 (COVID-19).

29 Nov 2020

Study exposes human olfactory and brain cells as genuine viral targets of SARS-CoV-2

In a study published in the iScience journal, a research group from Switzerland shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptors and entry genes are expressed in the human olfactory neuroepithelial cells and brain by observing key molecular players implicated in the infectious process

29 Nov 2020

MARA project aims to use new DNA based nanotechnology to fight bacteria

Antibiotics are used to prevent and treat bacterial infections. They have played a major role in combating infectious diseases such as tuberculosis, pneumonia, typhoid fever, and meningitis in 20th century.

27 Nov 2020

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

A recent study reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the viral replication SARS-CoV-2.

27 Nov 2020

SARS-CoV-2 launches multipronged attack against host cell protein synthesis, study finds

An interesting new study throws a flood of light on how SARS-CoV-2 accomplishes its mission to infect and replicate within host cells while evading the host immune response.

27 Nov 2020

SARS-CoV-2 spike protein shows slow but stable evolution, study finds

A new preprint published in November 2020 describes the seven different clades into which the virus has diversified.

27 Nov 2020

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

A new study reports a very promising anti-SARS-CoV-2 monoclonal antibody, HB27, that appears to have two distinct mechanisms of action inhibiting the virus-host cell interaction and subsequent infection.

27 Nov 2020

Could beta-blockers be a potential treatment for COVID-19?

News-Medical spoke to researchers about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19.

27 Nov 2020

N439K mutation of SARS-CoV-2 may be more infectious and antibody resistant than Wuhan strain

Researchers from the Harbin Institute of Technology, China, modeled the complexes formed between the RBD and the human ACE2 and monoclonal antibodies.

27 Nov 2020

Asian countries need support to get equitable access to COVID-19 vaccines

As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.

27 Nov 2020

Ipom-F inhibits SARS-CoV-2 infection in vitro

An international team of researchers showed the small molecule inhibitor, ipomoeassin F (Ipom-F), blocks the translocation/insertion of the three protein targets for SARS-CoV-2 infection.

27 Nov 2020